NCT01959165 - MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 21, 2013

Primary Completion Date

August 11, 2015

Study Completion Date

April 10, 2018

Conditions

Ulcerative Colitis

Interventions

DRUG

MEDI7183 low dose

MEDI7183 will be administered by SC on Day 1, Week 2, 4, and 8

DRUG

MEDI7183 medium dose

MEDI7183 will be administered by SC on Day 1, Week 2, 4, and 8

DRUG

MEDI7183 high dose

MEDI7183 will be administered by SC on Day 1, and placebo for MEDI7183 at Week 2, 4, and 8

DRUG

Matching Placebo

Placebo will be administered by SC on Day 1, Week 2,4, and 8

Trial Locations (23)

818-8502

Research Site, Chikushino-shi

583-0027

Research Site, Fujiidera-shi

720-8520

Research Site, Fukuyama-shi

432-8061

Research Site, Hamamatsu

892-0846

Research Site, Kagoshima

247-0056

Research Site, Kamakura-shi

606-8507

Research Site, Kyoto

612-8555

Research Site, Kyoto

108-8642

Research Site, Minatoku

020-8505

Research Site, Morioka

950-1104

Research Site, Niigata

663-8501

Research Site, Nishinomiya-shi

545-8586

Research Site, Osaka

870-0033

Research Site, Ōita

285-8741

Research Site, Sakura-shi

004-0041

Research Site, Sapporo

060-0033

Research Site, Sapporo

065-0033

Research Site, Sapporo

350-1305

Research Site, Sayama-shi

141-0022

Research Site, Shinagawa-ku

169-0073

Research Site, Shinjuku-ku

510-0016

Research Site, Yokkaichi-shi

236-0004

Research Site, Yokohama